Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2012
06/14/2012US20120148605 Immunomodulatory Methods And Systems For Treatment And/Or Prevention Of Atherosclerosis And Related Proteins, Peptide And Compositions
06/14/2012US20120148600 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use
06/14/2012US20120148599 Methods and compositions for neural disease immunotherapy
06/14/2012US20120148597 Human monoclonal antibodies to ctla-4
06/14/2012US20120148596 Molecular conjugates comprising human monoclonal antibodies to dendritic cells
06/14/2012US20120148594 Mimotopes of hiv and uses thereof
06/14/2012US20120148593 Neutralizing Antibodies And Methods Of Use Thereof
06/14/2012US20120148592 Neutralizing anti-ccl20 antibodies
06/14/2012US20120148591 Antibodies That Bind Amyloid Oligomers
06/14/2012US20120148590 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
06/14/2012US20120148589 Human cancer-related gene, its encoded products and applications
06/14/2012US20120148583 Cytokine antagonists for neurological and neuropsychiatric disorders
06/14/2012US20120148582 Engineered anti-il-23r antibodies
06/14/2012US20120148580 Methods for identification of sites for igg conjugation
06/14/2012US20120148578 Methods and compositions for inhibiting cd32b expressing cells
06/14/2012US20120148575 Methods Of Reducing Eosinophil Levels
06/14/2012US20120148573 Compositions and methods for the diagnosis and treatment of immune disorders
06/14/2012US20120148572 Novel antibodies
06/14/2012US20120148571 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and uses thereof
06/14/2012US20120148570 Methods and compositions for treating respiratory disease-challenged animals
06/14/2012US20120148568 Variant Immunoglobulins with Improved Manufacturability
06/14/2012US20120148566 Product and method for treatment of conditions associated with receptor-desensitization
06/14/2012US20120148565 Increasing lifespan by modulation of wwp-1 and ubc-18
06/14/2012US20120148555 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/14/2012US20120148552 Method and compositions for enhanced anti-tumor effector functioning of t cells
06/14/2012US20120148498 Compositions and Methods for the Systemic Treatment of Arthritis
06/14/2012US20120148490 Anti-ngf compositions and use thereof
06/14/2012CA2820681A1 Use of chimeric antigen receptor-modified t cells to treat cancer
06/14/2012CA2820671A1 Tnf-.alpha. binding proteins
06/14/2012CA2820630A1 Dimeric molecular complexes with free cysteine residues and conjugates thereof
06/14/2012CA2820382A1 Antitumor combinations containing antibodies recognizing specifically cd38 and bortezomib
06/14/2012CA2820134A1 Human monoclonal antibody
06/14/2012CA2820039A1 Immunoassay of cofilin 1 protein
06/14/2012CA2819861A1 Novel modulators and methods of use
06/14/2012CA2819810A1 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
06/14/2012CA2819038A1 Humanized antibodies to liv-1 and use of same to treat cancer
06/14/2012CA2818635A1 Antibodies selective for cells presenting erbb2 at high density
06/14/2012CA2818313A1 Anti ccr4 antibodies and uses thereof
06/13/2012EP2463369A1 Humanized anti-amyloid-b oligomer antibody
06/13/2012EP2463368A1 Humanized anti-amyloid-b oligomer antibody
06/13/2012EP2463307A1 Modified chaperonin 10
06/13/2012EP2463306A1 Method for immunizing an avian species
06/13/2012EP2463305A1 Antibodies to OX-2/CD200 and uses thereof
06/13/2012EP2463304A2 Monoclonal antibodies that neutralize anthrax toxins
06/13/2012EP2463303A2 Monoclonal antibodies that neutralize anthrax toxins
06/13/2012EP2463302A1 Multivalent immunoglobulins modified in the structural loop region
06/13/2012EP2462948A1 Bacterial virulence factors and uses thereof
06/13/2012EP2462165A1 Method for in vivo expansion of t regulatory cells
06/13/2012EP2462164A2 Lung cancer biomarkers
06/13/2012EP2462163A1 Beta cell marker antibody
06/13/2012EP2462162A1 Antibodies that specifically bind to a beta oligomers and use thereof
06/13/2012EP2462161A1 Antibodies that specifically bind to a beta oligomers and use thereof
06/13/2012EP2462160A1 Porphyromonas gingivalis polypeptides
06/13/2012EP2462159A1 Immunogenic composition comprising variants of staphylococcal clumping factor a
06/13/2012EP2462158A1 Method to improve virus removal in protein purification
06/13/2012EP2462157A1 Methods for purifying a target protein from one or more impurities in a sample
06/13/2012EP1957540B1 Binding polypeptides and uses thereof
06/13/2012EP1812058B1 Chlamydia trachomatis antigens for vaccine and diagnostic use
06/13/2012EP1745076B1 Antibodies specific for glycoprotein vi and methods of producing these antibodies
06/13/2012EP1720571B1 Method of treating hemolytic disease
06/13/2012EP1613273B1 Recombinant il-9 antibodies and uses thereof
06/13/2012EP1609804B1 Construct comprising recognition domain of antibody against von willebrand factor-specific cleaving enzyme
06/13/2012EP1597382B1 Genetically modified non-human mammals and cells
06/13/2012EP1587837B1 Epitope sequences for prostate cancer diagnosis and treatment
06/13/2012EP1587542B1 Use of anti-cd100 antibodies
06/13/2012EP1554311B1 Humanized antibodies that recognize beta amyloid peptide
06/13/2012EP1495053B1 Angiopoietin-2 and angiopoietin-1 specific binding agents
06/13/2012EP1490110B1 Anti-alpha v beta 6 antibodies
06/13/2012EP1480666B1 Immunizing composition and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein
06/13/2012EP1414471B1 Therapeutic agents comprising pro-apoptotic proteins
06/13/2012EP1355666B1 Use of repulsive guidance molecule (RGM) and its modulators
06/13/2012EP1297017B1 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
06/13/2012EP1296705B1 Amyloid Beta oligomers for use in treatment, alleviation or prevention of Alzheimer's Disease
06/13/2012EP0904288B1 Vaccine comprising the pathogenic escherichia coli associated protein espa
06/13/2012EP0451216B2 Humanized immunoglobulins and their production and use
06/13/2012CN1835976B Aglycosyl anti- CD154 (CD 40 ligand) antibodies and uses thereof
06/13/2012CN1688337B Use of digoxin immune FAB (ovine) for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients
06/13/2012CN102498130A Induction of P53 expression by neutralization of neuropilin-2 for the treatment of cancers
06/13/2012CN102498129A Inhibition of tumor metastasis using bv8- or g-csf-antagonists
06/13/2012CN102492702A Beta-nodavirus genome complete sequence and cloning method thereof
06/13/2012CN102492671A 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) polypeptide antigen and its preparation method and application
06/13/2012CN102492658A PSer86 monoclonal antibody of Tip60, as well as preparation method and application of pSer86 monoclonal antibody
06/13/2012CN102492040A Method for purifying anti-HER2 or/and anti-HER3 antibody proteins
06/13/2012CN102492039A Fully humanized antihuman HER2 monoclonal antibody
06/13/2012CN102492038A Anti-human Tim-3 neutralized monoclonal antibody L3D and application thereof
06/13/2012CN102492037A High affinity fusarium specific single-chain antibody and preparation method thereof
06/13/2012CN102492036A Method for extracting egg yolk antibody of exinfectious bursal disease
06/13/2012CN102492035A Preparation method for purifying yolk antibody
06/13/2012CN102488899A Preparation method and application of yolk immunoglobulin sustained-release preparation
06/13/2012CN101570574B Anti-I type Shiga toxin IgY antibody as well as preparation method and use thereof
06/13/2012CN101331150B Human monoclonal antibody human CD134 (OX40) and methods of making and using same
06/12/2012US8198508 Reducing the risk of human anti-human antibodies through V gene manipulation
06/12/2012US8198417 Potent, durable cytotoxic agents; tissue targeted therapy; tumors, autoimmune diseases, graft versus host disease, viral and parasite infections
06/12/2012US8198416 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
06/12/2012US8198415 Anti-rhesus D recombinant polyclonal antibody
06/12/2012US8198414 Isolated binding member, human antibody molecules, which bind interleukin-6 (IL-6) and neutralise its biological effects; inflammatory diseases and tumours associated with IL-6
06/12/2012US8198412 Antibodies that recognize cutting edge within the TGF-β activation controlling region
06/12/2012US8198411 Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer
06/12/2012US8198410 Nerve growth factor specific immunoglobulin for prevention and treatment of chronic pain, nervous system, inflammatory, skin and bone disorders; osteoarthritis
06/12/2012US8198404 Mutated immunoglobulin-binding protein
1 ... 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 ... 1494